Hansoh Pharmaceutical Group Company Limited (HKG:3692)
29.40
-0.50 (-1.67%)
Jun 13, 2025, 4:08 PM HKT
HKG:3692 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Market Capitalization | 174,808 | 102,545 | 93,358 | 87,864 | 112,525 | 222,554 | Upgrade
|
Market Cap Growth | 9.84% | 9.84% | 6.25% | -21.92% | -49.44% | 48.44% | Upgrade
|
Enterprise Value | 150,011 | 77,426 | 72,847 | 68,167 | 95,387 | 204,073 | Upgrade
|
Last Close Price | 29.40 | 17.28 | 15.47 | 14.41 | 18.26 | 36.05 | Upgrade
|
PE Ratio | 37.60 | 22.04 | 25.86 | 30.08 | 33.79 | 72.95 | Upgrade
|
Forward PE | 34.83 | 24.05 | 28.31 | 24.97 | 27.09 | 54.85 | Upgrade
|
PS Ratio | 13.40 | 7.86 | 8.39 | 8.28 | 9.23 | 21.56 | Upgrade
|
PB Ratio | 5.73 | 3.36 | 3.29 | 3.43 | 4.58 | 10.48 | Upgrade
|
P/TBV Ratio | 5.78 | 3.39 | 3.31 | 3.44 | 4.58 | 10.49 | Upgrade
|
P/FCF Ratio | 45.12 | 26.47 | 29.25 | 31.49 | 43.30 | 194.63 | Upgrade
|
P/OCF Ratio | 42.53 | 24.95 | 27.19 | 28.35 | 35.57 | 78.39 | Upgrade
|
PEG Ratio | 5.12 | 3.63 | 3.12 | 1.56 | 1.11 | 1.97 | Upgrade
|
EV/Sales Ratio | 11.50 | 5.93 | 6.54 | 6.43 | 7.82 | 19.77 | Upgrade
|
EV/EBITDA Ratio | 32.76 | 17.01 | 21.86 | 20.57 | 25.20 | 57.49 | Upgrade
|
EV/EBIT Ratio | 36.13 | 18.65 | 24.68 | 23.13 | 27.55 | 61.97 | Upgrade
|
EV/FCF Ratio | 38.72 | 19.99 | 22.83 | 24.43 | 36.71 | 178.47 | Upgrade
|
Debt / Equity Ratio | 0.00 | 0.00 | 0.17 | 0.19 | 0.19 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 0.03 | 0.03 | 1.41 | 1.48 | 1.24 | 0.03 | Upgrade
|
Debt / FCF Ratio | 0.03 | 0.03 | 1.49 | 1.77 | 1.81 | 0.10 | Upgrade
|
Asset Turnover | 0.38 | 0.38 | 0.32 | 0.33 | 0.41 | 0.43 | Upgrade
|
Inventory Turnover | 1.82 | 1.82 | 2.02 | 2.03 | 2.46 | 2.25 | Upgrade
|
Quick Ratio | 9.90 | 9.90 | 4.11 | 9.64 | 7.50 | 6.30 | Upgrade
|
Current Ratio | 10.18 | 10.18 | 4.21 | 9.86 | 7.67 | 6.43 | Upgrade
|
Return on Equity (ROE) | 16.05% | 16.05% | 13.53% | 12.11% | 14.31% | 16.62% | Upgrade
|
Return on Assets (ROA) | 7.54% | 7.54% | 5.31% | 5.70% | 7.35% | 8.59% | Upgrade
|
Return on Capital (ROIC) | 8.28% | 8.28% | 5.86% | 6.41% | 8.43% | 11.17% | Upgrade
|
Return on Capital Employed (ROCE) | 13.50% | 13.50% | 10.20% | 9.50% | 11.70% | 15.30% | Upgrade
|
Earnings Yield | 2.66% | 4.54% | 3.87% | 3.32% | 2.96% | 1.37% | Upgrade
|
FCF Yield | 2.22% | 3.78% | 3.42% | 3.18% | 2.31% | 0.51% | Upgrade
|
Dividend Yield | 1.12% | 1.95% | 1.38% | 0.69% | 0.49% | 0.21% | Upgrade
|
Payout Ratio | 42.51% | 42.51% | 19.90% | 27.56% | 14.04% | 163.49% | Upgrade
|
Buyback Yield / Dilution | 1.16% | 1.16% | -1.52% | 1.14% | -2.04% | -7.31% | Upgrade
|
Total Shareholder Return | 2.28% | 3.10% | -0.14% | 1.83% | -1.55% | -7.10% | Upgrade
|
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.